SCHEMBL4449758

SCHEMBL4449758

Clc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1.Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 14/20 0.65
DRD3 P35462 14/20 0.65
DRD4 P21917 12/20 0.65
HTR2A P28223 11/20 0.61
DRD1 P21728 9/20 0.61
DRD5 P21918 5/20 0.61
HTR1A P08908 3/20 0.53
SIGMAR1 Q99720 2/20 0.53
TMEM97 Q5BJF2 1/20 0.53
HRH1 P35367 2/20 0.48
HRH3 Q9Y5N1 2/20 0.48
HRH2 P25021 1/20 0.48
HTR7 P34969 1/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3614855 0.95 DRD3 (0.66) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3611604 0.95 DRD2 (0.70) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3617086 0.84 DRD2 (0.72) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3653325 0.83 DRD2 (0.65) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3612201 0.81 DRD2 (0.86) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL4441975 0.81 DRD2 (0.73) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3603446 0.80 DRD3 (0.66) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL4451501 0.79 DRD2 (0.73) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3615538 0.78 DRD3 (1.00) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3615769 0.78 DRD2 (0.80) DRD2DRD3DRD4HTR2ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137185-A2 INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS Gmeiner, Dr. Peter (DE) 2009-12-30 EP claimed
WO-2008113559-A2 INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS SCHWARZ PHARMA AG (DE) 2008-09-25 WO claimed